-
Product Insights
Likelihood of Approval Analysis for Systemic Candidiasis
Overview How likely is it that the drugs in Systemic Candidiasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Systemic Candidiasis Overview Systemic candidiasis encompasses a range of yeast infections resulting...
-
Product Insights
Likelihood of Approval Analysis for Complicated Intra-Abdominal Infections
Overview How likely is it that the drugs in Complicated Intra-Abdominal Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Complicated Intra-Abdominal Infections Overview Complicated intra-abdominal infections (cIAIs) are infections that...
-
Product Insights
Likelihood of Approval Analysis for Fungal Infections
Overview How likely is it that the drugs in Fungal Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fungal Infections Overview Fungal infections are diseases caused by different types of...
-
Product Insights
Likelihood of Approval Analysis for Lupus Nephritis
Overview How likely is it that the drugs in Lupus Nephritis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lupus Nephritis Overview Lupus nephritis is a severe complication of systemic lupus...
-
Product Insights
Likelihood of Approval Analysis for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease)
Overview How likely is it that the drugs in Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) Overview Systemic-onset...
-
Product Insights
Likelihood of Approval Analysis for Mycosis Fungoides
Overview How likely is it that the drugs in Mycosis Fungoides will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mycosis Fungoides Overview Mycosis fungoides is a rare type of non-Hodgkin lymphoma,...
-
Sector Analysis
NewMobility Market Size, Trends, Drivers and Challenges, Vendor Landscape, Opportunities and Forecast to 2027
Mobility Market Report Overview The global mobility market size was pegged at more than $36 billion in 2022. The market is expected to grow at a CAGR of more than 15% during the forecast period (2022-2027). The significant rise in the adoption of mobile solutions in enterprises has led to a parallel rise in demand for enterprise mobility management (EMM) solutions, which enable IT administrators to simplify and secure enterprise mobility implementations in their organizations. Mobility Market Outlook, 2022-2027 ($...
-
Product Insights
Likelihood of Approval Analysis for Metastatic Uveal Melanoma
Overview How likely is it that the drugs in Metastatic Uveal Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Uveal Melanoma Overview Metastatic uveal melanoma is a rare and...
-
Sector Analysis
NewReconstruction Meshes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Reconstruction Meshes Market Report Overview The Reconstruction Meshes market size was $2.38 billion in 2023. Factors such as the rising number of breast reconstruction procedures and the growing prevalence of Pelvic Organ Prolapse (POP) will drive the market growth at a CAGR of more than 1% from 2023 to 2033. Reconstruction Meshes Market Outlook 2023-2033 ($ Billion) Buy the Full Report for More Insights on the Reconstruction Meshes Market Forecast, Download a Free Sample Report The Reconstruction Meshes market research...
-
Analyst Opinions
NewBiogas Market Trends and Analysis by Technology, Region, Key Players and Recent Developments, 2024 Update
Biogas is a renewable technology that can lessen the impact on the environment as an alternative to fossil fuels. However, its growth will need to increase drastically if it is to meet the IEA's NZE targets. Humans, directly or indirectly, generate over 105B tonnes of organic waste globally each year, all of which release harmful methane and other GHG emissions directly into the atmosphere as they decompose. Today, only 2% of such waste is treated and recycled. This percentage only...